Phase I/II trial of Zoledronic Acid plus Interleukin-2 in patients with solid and hematological malignancies

Manfred Smetak; V Kunzmann; B Kimmel; K Weigang-Koehler; M Goebeler; Josef Birkmann; J Becker; I Schmidt-Wolf; H Einsele; Martin Wilhelm

Phase I/II trial of Zoledronic Acid plus Interleukin-2 in patients with solid and hematological malignancies

Manfred Smetak, V Kunzmann, B Kimmel, K Weigang-Koehler, M Goebeler, Josef Birkmann, J Becker, I Schmidt-Wolf, H Einsele, Martin Wilhelm

Department of Internal Medicine V, Division of Oncology and Hematology

Research output: Contribution to journal › published Abstract (Journal) › peer-review

Original language	English
Pages (from-to)	279-279
Journal	ONKOLOGIE
Volume	33
Publication status	Published - 2010

Cite this

Smetak, M., Kunzmann, V., Kimmel, B., Weigang-Koehler, K., Goebeler, M., Birkmann, J., Becker, J., Schmidt-Wolf, I., Einsele, H., & Wilhelm, M. (2010). Phase I/II trial of Zoledronic Acid plus Interleukin-2 in patients with solid and hematological malignancies. ONKOLOGIE , 33, 279-279.

Smetak, Manfred ; Kunzmann, V ; Kimmel, B et al. / Phase I/II trial of Zoledronic Acid plus Interleukin-2 in patients with solid and hematological malignancies. In: ONKOLOGIE 2010 ; Vol. 33. pp. 279-279.

@article{c0f31428078845de997cf2508d9ab05d,

title = "Phase I/II trial of Zoledronic Acid plus Interleukin-2 in patients with solid and hematological malignancies",

author = "Manfred Smetak and V Kunzmann and B Kimmel and K Weigang-Koehler and M Goebeler and Josef Birkmann and J Becker and I Schmidt-Wolf and H Einsele and Martin Wilhelm",

year = "2010",

language = "English",

volume = "33",

pages = "279--279",

journal = "ONKOLOGIE ",

issn = "0378-584X",

}

Smetak, M, Kunzmann, V, Kimmel, B, Weigang-Koehler, K, Goebeler, M, Birkmann, J, Becker, J, Schmidt-Wolf, I, Einsele, H & Wilhelm, M 2010, 'Phase I/II trial of Zoledronic Acid plus Interleukin-2 in patients with solid and hematological malignancies', ONKOLOGIE , vol. 33, pp. 279-279.

Phase I/II trial of Zoledronic Acid plus Interleukin-2 in patients with solid and hematological malignancies. / Smetak, Manfred; Kunzmann, V; Kimmel, B et al.
In: ONKOLOGIE , Vol. 33, 2010, p. 279-279.

Research output: Contribution to journal › published Abstract (Journal) › peer-review

TY - JOUR

T1 - Phase I/II trial of Zoledronic Acid plus Interleukin-2 in patients with solid and hematological malignancies

AU - Smetak, Manfred

AU - Kunzmann, V

AU - Kimmel, B

AU - Weigang-Koehler, K

AU - Goebeler, M

AU - Birkmann, Josef

AU - Becker, J

AU - Schmidt-Wolf, I

AU - Einsele, H

AU - Wilhelm, Martin

PY - 2010

Y1 - 2010

M3 - published Abstract (Journal)

SN - 0378-584X

VL - 33

SP - 279

EP - 279

JO - ONKOLOGIE

JF - ONKOLOGIE

ER -

Smetak M, Kunzmann V, Kimmel B, Weigang-Koehler K, Goebeler M, Birkmann J et al. Phase I/II trial of Zoledronic Acid plus Interleukin-2 in patients with solid and hematological malignancies. ONKOLOGIE . 2010;33:279-279.